Navigation Links
PDI Reports 2009 Third Quarter Financial Results
Date:11/5/2009

strategic initiatives relating to leveraging and expanding its core CSO capabilities, expanding its range of integrated, value-added services and reducing expenses, adverse changes in outsourcing trends in the pharmaceutical industry or a reduction or elimination of the role of pharmaceutical sales representatives. Also, with respect to statements regarding anticipated future savings relating to the impending relocation of our corporate headquarters, these savings may be offset in whole or in part by expenses associated with the lease for our current corporate headquarters unless we are able to successfully sublet this facility in a timely manner. Additionally, all forward-looking statements are subject to the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2008, and PDI's subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K. Because of these and other risks, uncertainties and assumptions, undue reliance should not be placed on these forward-looking statements. In addition, these statements speak only as of the date of this press release and, except as may be required by law, PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.


                                  PDI, INC.
         CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
                  (in thousands, except for per share data)

                                      Three Months        Nine Months
                                          Ended              Ended
                                      September 30,      September 30,
                                      -------------      -------------
                                      2009     2008      2009      2008
                                      ----     ----      ----      ----

    
'/>"/>
SOURCE PDI, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
2. Symmetry Medical Reports Third Quarter 2009 Financial Results
3. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
4. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
5. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
6. HeartWare International Reports Third Quarter Revenues of $7.5 Million
7. Varian, Inc. Reports Fourth Quarter 2009 Results
8. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
9. Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
10. Cambrex Reports Third Quarter 2009 Results
11. Regeneron Reports Third Quarter 2009 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015   Regulus Therapeutics Inc . ( NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... quarter ended June 30, 2015 on Tuesday, August 4, ... Regulus will host a conference call and webcast ... Daylight Time to discuss its second quarter 2015 financial ...
(Date:7/28/2015)... -- Express Scripts Holding Company (Nasdaq: ESRX ) announced ... stockholders of $600.1 million, or $0.88 per diluted share.  ... 4, were $1.44 for the second quarter. 1  ... healthcare are validating the need for size and scale," ... what matters most is how that size and scale ...
(Date:7/28/2015)... 2015 On the afternoon of August 11, ... CPI International, Inc. (CPI), plans to file its Form ... with the Securities and Exchange Commission and to issue ...  At 11 a.m. (EDT) on Wednesday, August 12, 2015, ... with this release that will be Web cast simultaneously ...
Breaking Medicine Technology:Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25CPI International To Announce Third Quarter 2015 Financial Results 2
... Incorporated (Nasdaq: VPHM ) today announced initiation ... safety and efficacy of C1 Esterase Inhibitor [Human] for ... of donor-specific cross-match positive kidney transplants. ... safety, tolerability and clinical effect of C1 Esterase Inhibitor ...
... SIAL ) announced the release of the first ... site has been redesigned to support and enhance scientific workflow ... information, tools, products and services they need to accelerate research ... innovative upgrades to the site over the next twelve months. ...
Cached Medicine Technology:ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR) 2ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR) 3ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR) 4ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR) 5Sigma-Aldrich Unveils Dynamic New Web Presence 2Sigma-Aldrich Unveils Dynamic New Web Presence 3
(Date:7/29/2015)... ... July 29, 2015 , ... For the second year in ... in the list of the 50 fastest growing companies in Jacksonville. This annual list ... community. On July 16th, a team of Vast Bridges staffers were on hand to ...
(Date:7/29/2015)... , ... July 29, 2015 , ... CanAm Enterprises, LLC ... USCIS over the past month! I-829 approvals have been granted to investors in four ... Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the Valley Forge Convention Center ...
(Date:7/29/2015)... MD (PRWEB) , ... July 29, 2015 , ... A ... Get Checked for Skin Cancer ," discussed the importance of having regular skin cancer ... a person has excessive exposure to ultraviolet rays. When caught early, skin cancer is ...
(Date:7/29/2015)... ... , ... Several years ago, in order to be in the strongest position ... proactive stance and began planning the Children’s Village consisting of six homes. , Two ... the third home. , “We are very pleased to have received the $500,000 grant ...
(Date:7/29/2015)... ... July 29, 2015 , ... Toronto native ... late 1970s, Dr. Cottrell has been making predictions about the economy, politics, social ... many of these prognostications. He warns that extreme weather conditions and increased earthquake ...
Breaking Medicine News(10 mins):Health News:Vast Bridges Continues Its Swift Growth 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2
... Thomas Lescault, president of SCAN Long Term Care and ... the new Arizona Association of Health Plans. "The new ... providing accessible, affordable healthcare here in Arizona," said Lescault. ... the Arizona Legislature and the governor,s office in adjusting ...
... today by Every Child By Two:The U.S. Court of ... the causes of autism. The three judges ruled ... thimerosal-containing vaccines, does not cause autism. The ruling ... failed to show a link between vaccines and the ...
... don,t respond to current treatments, study finds , , ... shows promise against psoriatic arthritis (PA), according to a ... and North America. , PA affects about 11 percent ... the skin and joints. Some patients don,t respond to ...
... rhinoviruses now sequenced, could lead to new treatments, researchers ... medical breakthrough: a cure for the common cold. , ... a significant step in that direction: the genetic codes ... nasal infections. , "There has been brilliant work done ...
... Spencer Inc.,(NYSE: CSA ) announces the promotion ... the Company,s wholly owned subsidiary, Erdman, A Cogdell,Spencer Company ... Company,s Atlanta office, Ms. Dorr will focus on developing,and ... and development projects in the Region, which includes Georgia,Florida, ...
... N.J., Feb. 12 The Journal of Commerce Conferences, ... will take place May 12 and 13, 2009, at ... the event is "Linking Up the Cold Chain," and ... refrigerated and frozen cargo, will be the conference host.Cool ...
Cached Medicine News:Health News:SCAN's Thomas Lescault Elected President of New Arizona Association of Health Plans 2Health News:Federal Court Declares Vaccines Do Not Cause Autism 2Health News:Drug Reduces Inflammatory Arthritis Symptoms, Lesions 2Health News:Genetic Code of Common Cold Cracked 2Health News:Genetic Code of Common Cold Cracked 3Health News:Cogdell Spencer Announces Dorr as President of the Southeast Region 2Health News:Cogdell Spencer Announces Dorr as President of the Southeast Region 3Health News:'Linking Up the Cold Chain' is Focus of The JoC Conferences' First Cool Cargoes Conference, May 12-13, in Portland, Oregon 2Health News:'Linking Up the Cold Chain' is Focus of The JoC Conferences' First Cool Cargoes Conference, May 12-13, in Portland, Oregon 3
... St. Jude Medical is the world ... introducers are used worldwide for permanent ... venous catheter and port implantation, and ... design of St. Jude Medical Peel-Away ...
This unique hemostatic seal provides a simple option for beating heart CABG anastomoses, allowing you to use your own hand-suturing technique without the release of cerebral emboli associated with th...
The RX HERCULINK® PLUS Biliary Stent System is Guidant's high performance .014" guide wire compatible system. It is available in stent diameters of 4.0-6.5mm for the 12mm stent length and 4.0-7.0...
... The OMNILINK®.035 Biliary Stent System is a supportive .035" ... 5.0 - 10.0 mm in lengths of 18 mm, ... - 7.0 mm diameters available in 12 and 16 ... available in 18mm lengths. Two "diameter specific" OMNILINK® ...
Medicine Products: